Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prime & Bond NT is a light-cured, self-priming dental adhesive and bonding agent developed by Dentsply Sirona. It is primarily used in restorative dentistry to bond composite materials to enamel and dentin. The formulation incorporates nanofiller technology, specifically amorphous silicon dioxide, which improves its mechanical properties and ensures a uniform adhesive layer. In the context of clinical research at Universidad El Bosque, Bogotá, Prime & Bond NT was investigated as a non-invasive treatment for proximal dental caries. By sealing the surface of early carious lesions, the material acts as a physical barrier that prevents the diffusion of fermentable carbohydrates to the bacteria within the lesion and blocks the egress of acidic metabolic byproducts, thereby arresting the progression of the decay.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prime & Bond NT.